Rewiring of Molecular Networks Induced by the Combination of Loratadine, Raloxifene, and Sorafenib Leads to the Identification of Clinically Relevant Therapeutic Targets in Hepatocellular Carcinoma.
- DOI
- 10.3390/biomedicines14091898
- Published
- 2026 Aug 25
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines14091898,
title = {Rewiring of Molecular Networks Induced by the Combination of Loratadine, Raloxifene, and Sorafenib Leads to the Identification of Clinically Relevant Therapeutic Targets in Hepatocellular Carcinoma.},
author = {Villarruel-Melquiades F and Santos-Martínez N and Noyola-Díaz M and Terán-Sánchez EJ and Serrano-Contreras JI and Zepeda-Vallejo LG and Mendoza-Garrido ME and Pérez-Carreón JI and Bañuelos C and Hernández-Montes G and Camacho J},
year = {2026},
journal = {Biomedicines},
doi = {10.3390/biomedicines14091898},
url = {https://doi.org/10.3390/biomedicines14091898}
}RIS
TY - JOUR TI - Rewiring of Molecular Networks Induced by the Combination of Loratadine, Raloxifene, and Sorafenib Leads to the Identification of Clinically Relevant Therapeutic Targets in Hepatocellular Carcinoma. AU - Villarruel-Melquiades F AU - Santos-Martínez N AU - Noyola-Díaz M AU - Terán-Sánchez EJ AU - Serrano-Contreras JI AU - Zepeda-Vallejo LG AU - Mendoza-Garrido ME AU - Pérez-Carreón JI AU - Bañuelos C AU - Hernández-Montes G AU - Camacho J PY - 2026 JO - Biomedicines DO - 10.3390/biomedicines14091898 UR - https://doi.org/10.3390/biomedicines14091898 ER -
APA
F, V., N, S., M, N., EJ, T., JI, S., LG, Z., ME, M., JI, P., C, B., G, H., & J, C. (2026). Rewiring of Molecular Networks Induced by the Combination of Loratadine, Raloxifene, and Sorafenib Leads to the Identification of Clinically Relevant Therapeutic Targets in Hepatocellular Carcinoma.. Biomedicines. https://doi.org/10.3390/biomedicines14091898
Source records
- pubmed · retrieved 2026-09-26T18:58:21.477Z